A detailed history of Corton Capital Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Corton Capital Inc. holds 39,491 shares of BCRX stock, worth $307,239. This represents 0.15% of its overall portfolio holdings.

Number of Shares
39,491
Holding current value
$307,239
% of portfolio
0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.41 - $8.69 $253,137 - $343,176
39,491 New
39,491 $300,000
Q4 2022

Feb 14, 2023

BUY
$10.5 - $14.2 $120,960 - $163,584
11,520 New
11,520 $132,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.45B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.